Leistungsbewertungsprüfung: Atemluftanalyse für Die Diagnose Von Brustkrebs, für Die Überwachung Der Therapie Und für Die Voraussage Des Metastasenrisikos
N/A
18 Years
85 Years
18 Years
85 Years
Not Enrolling
Female
Mamma Carcinoma
Female
Mamma Carcinoma
Trial Information
Leistungsbewertungsprüfung: Atemluftanalyse für Die Diagnose Von Brustkrebs, für Die Überwachung Der Therapie Und für Die Voraussage Des Metastasenrisikos
Inclusion Criteria:
- Mamma carcinoma diagnosed by histology (cases)
- Mamma carcinoma excluded by radiology (controls)
- At the time of diagnosis before surgery
- At the beginning and during chemotherapy;
Exclusion Criteria:
- No informed consent form singed
Type of Study:
Observational
Study Design:
Observational Model: Case Control, Time Perspective: Prospective
Outcome Measure:
Breath gas markers
Outcome Description:
Breath gas markers that allow to distinguish patients with mamma carcinoma from women without carcinoma;
Outcome Time Frame:
3 years
Safety Issue:
No
Authority:
Austria: Agency for Health and Food Safety
Study ID:
BC1
NCT ID:
NCT01105468
Start Date:
April 2010
Completion Date:
April 2017
Related Keywords:
- Mamma Carcinoma
- Breath gas analysis
- Volatile components in exhaled breath
- Carcinoma
Name | Location |
|---|
